Logo image of ADAG

ADAGENE INC-ADR (ADAG) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ADAG - US0053291078 - ADR

1.88 USD
0 (0%)
Last: 12/23/2025, 9:43:48 AM
Fundamental Rating

2

ADAG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 530 industry peers in the Biotechnology industry. ADAG has a bad profitability rating. Also its financial health evaluation is rather negative. ADAG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ADAG had negative earnings in the past year.
ADAG had a negative operating cash flow in the past year.
In the past 5 years ADAG always reported negative net income.
In the past 5 years ADAG always reported negative operating cash flow.
ADAG Yearly Net Income VS EBIT VS OCF VS FCFADAG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -44.94%, ADAG is in line with its industry, outperforming 54.34% of the companies in the same industry.
ADAG's Return On Equity of -78.84% is in line compared to the rest of the industry. ADAG outperforms 52.83% of its industry peers.
Industry RankSector Rank
ROA -44.94%
ROE -78.84%
ROIC N/A
ROA(3y)-35.43%
ROA(5y)-39.1%
ROE(3y)-63.08%
ROE(5y)-60.3%
ROIC(3y)N/A
ROIC(5y)N/A
ADAG Yearly ROA, ROE, ROICADAG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ADAG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADAG Yearly Profit, Operating, Gross MarginsADAG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -10K -20K -30K

More info and screens

2

2. Health

2.1 Basic Checks

ADAG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ADAG has been increased compared to 1 year ago.
Compared to 5 years ago, ADAG has more shares outstanding
The debt/assets ratio for ADAG is higher compared to a year ago.
ADAG Yearly Shares OutstandingADAG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ADAG Yearly Total Debt VS Total AssetsADAG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ADAG has an Altman-Z score of -5.96. This is a bad value and indicates that ADAG is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.96, ADAG is doing worse than 64.91% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that ADAG is not too dependend on debt financing.
ADAG's Debt to Equity ratio of 0.06 is on the low side compared to the rest of the industry. ADAG is outperformed by 61.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z -5.96
ROIC/WACCN/A
WACC7.17%
ADAG Yearly LT Debt VS Equity VS FCFADAG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ADAG has a Current Ratio of 2.29. This indicates that ADAG is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ADAG (2.29) is worse than 73.58% of its industry peers.
A Quick Ratio of 2.29 indicates that ADAG has no problem at all paying its short term obligations.
The Quick ratio of ADAG (2.29) is worse than 71.51% of its industry peers.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 2.29
ADAG Yearly Current Assets VS Current LiabilitesADAG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

ADAG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.98%, which is quite good.
ADAG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -87.35%.
ADAG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -26.47% yearly.
EPS 1Y (TTM)10.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
Revenue 1Y (TTM)-87.35%
Revenue growth 3Y-78.36%
Revenue growth 5Y-26.47%
Sales Q2Q%N/A

3.2 Future

ADAG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.90% yearly.
Based on estimates for the next years, ADAG will show a very strong growth in Revenue. The Revenue will grow by 47.58% on average per year.
EPS Next Y17.26%
EPS Next 2Y-5.08%
EPS Next 3Y5.02%
EPS Next 5Y4.9%
Revenue Next Year-22.52%
Revenue Next 2Y2.67%
Revenue Next 3Y-9.87%
Revenue Next 5Y47.58%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ADAG Yearly Revenue VS EstimatesADAG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M
ADAG Yearly EPS VS EstimatesADAG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ADAG. In the last year negative earnings were reported.
Also next year ADAG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADAG Price Earnings VS Forward Price EarningsADAG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADAG Per share dataADAG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.08%
EPS Next 3Y5.02%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ADAG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ADAGENE INC-ADR

NASDAQ:ADAG (12/23/2025, 9:43:48 AM)

1.88

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)03-23 2026-03-23/amc
Inst Owners26.19%
Inst Owner Change-57.05%
Ins Owners2.77%
Ins Owner ChangeN/A
Market Cap88.57M
Revenue(TTM)103.20K
Net Income(TTM)-29.89M
Analysts81.43
Price Target9.41 (400.53%)
Short Float %0.08%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.34%
PT rev (3m)-4.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)4.14%
EPS NY rev (3m)18.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.7%
Revenue NY rev (3m)-5.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 858.2
P/FCF N/A
P/OCF N/A
P/B 2.34
P/tB 2.34
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0
BVpS0.8
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -44.94%
ROE -78.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.43%
ROA(5y)-39.1%
ROE(3y)-63.08%
ROE(5y)-60.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.25%
Cap/Sales 22.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.29
Quick Ratio 2.29
Altman-Z -5.96
F-Score2
WACC7.17%
ROIC/WACCN/A
Cap/Depr(3y)24.44%
Cap/Depr(5y)80.95%
Cap/Sales(3y)13.48%
Cap/Sales(5y)39.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
EPS Next Y17.26%
EPS Next 2Y-5.08%
EPS Next 3Y5.02%
EPS Next 5Y4.9%
Revenue 1Y (TTM)-87.35%
Revenue growth 3Y-78.36%
Revenue growth 5Y-26.47%
Sales Q2Q%N/A
Revenue Next Year-22.52%
Revenue Next 2Y2.67%
Revenue Next 3Y-9.87%
Revenue Next 5Y47.58%
EBIT growth 1Y9.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.1%
EBIT Next 3Y-15.12%
EBIT Next 5YN/A
FCF growth 1Y-4.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.38%
OCF growth 3YN/A
OCF growth 5YN/A

ADAGENE INC-ADR / ADAG FAQ

What is the fundamental rating for ADAG stock?

ChartMill assigns a fundamental rating of 2 / 10 to ADAG.


What is the valuation status of ADAGENE INC-ADR (ADAG) stock?

ChartMill assigns a valuation rating of 0 / 10 to ADAGENE INC-ADR (ADAG). This can be considered as Overvalued.


What is the profitability of ADAG stock?

ADAGENE INC-ADR (ADAG) has a profitability rating of 1 / 10.